Apoptosis is closely linked to proliferation. In this study we showed that inducing apoptosis in mouse mesangial cells with ultraviolet (UV) irradiation was associated with increased cyclin A-cyclin dependent kinase (CDK) 2 activity. Inhibiting CDK2 activity with Roscovitine or dominant negative mutant reduced apoptosis. Because apoptosis typically begins in the cytoplasm, we tested the hypothesis that the subcellular localization of CDK2 determines the proliferative or apoptotic fate of the cell. Our results showed that cyclin A-CDK2 was nuclear in proliferating cells. However, inducing apoptosis in proliferating cells with UV irradiation was associated with a decrease in nuclear cyclin A and CDK2 protein levels. This coincided with an increase in protein and kinase activity for cyclin A-CDK2 in the cytoplasm. Translocation of cyclin A-CDK2 also occurred in p537/7 mesangial cells. Finally, we showed that caspase-3 activity was signi®-cantly reduced by inhibiting CDK2 activity with Roscovitine. In summary, our results show that apoptosis is associated with an increase in cytoplasmic cyclin A-CDK2 activity, which is p53 independent and upstream of caspase-3. We propose that the subcellular localization of CDK2 determines the proliferative or apoptotic fate of the cell.
Introduction
Apoptosis is a highly orchestrated form of programmed cell death required to maintain cell number. Under certain pathological states characterized by cell proliferation, such as in¯ammation and neoplasia, apoptosis is required to normalize cell number in order to maintain a normal tissue homeostasis (Chao and Korsmeyer, 1998; Miller and Marx, 1998; Minn et al., 1998) . Proliferation requires that cells progress through the cell cycle, which is governed by speci®c cell cycle regulatory proteins. Proliferation requires the activation of cyclin-dependent kinases (CDKs) by their partner cyclins during each phase of the cell cycle (Pines, 1994; Roussel, 1998; Shankland and Wolf, 2000; Sherr and Roberts, 1999) . CDK4 and CDK6 are activated by D-type cyclins during early G1, CDK2 is activated by cyclin E in G1/S and by cyclin A during S and G2/M, and cyclin B1 activates cdc2 during mitosis.
The traditional view is that the cell cycle is restricted to proliferation. However, recent studies have also shown a link between the cell cycle and apoptosis. There is a growing body of evidence showing that speci®c cyclin-CDKs participate in apoptosis. The activity of cdc2 (Shi et al., 1994; Yao et al., 1996) , CDK4 and CDK6 (Dobashi et al., 1998; Park et al., 1998) are increased in certain forms of apoptosis. Overexpressing CDK2 accelerates thymocyte cell death (Gil-Gomez et al., 1998) . Cyclin A overexpression induces apoptosis in rat ®broblasts exposed to low serum (Hoang et al., 1994) , and also circumvents the anti-apoptotic activity of Bcl-2 in HeLa cells (Meikrantz and Schlegel, 1996) . Recent studies have shown that cyclin A-CDK2 is active during apoptosis in the absence of DNA synthesis, and that inhibiting CDK2 activity reduces apoptosis (Adachi et al., 2001; Levkau et al., 1998; Meikrantz et al., 1994) . The association of speci®c cyclin-CDKs and apoptosis has also been shown in vivo. Mice transgenic for both cyclin A and CDK2 show a greater incidence of apoptosis (Bortner and Rosenberg, 1995) , and increased cyclin A-CDK2 activity coincides with a marked increase in apoptosis in in¯ammatory injury (Ophascharoensuk et al., 1998) . Taken together, these studies demonstrate that speci®c cyclin-CDK complexes are involved in both the proliferative and apoptotic pathways following injury. However, the precise mechanisms that determine this have not been clearly delineated.
Although DNA synthesis and mitosis are nuclear events, apoptosis typically begins in the cytoplasm (Green and Reed, 1998; Minn et al., 1998) . Accordingly, we tested the hypothesis that the subcellular localization of active CDK2 determines if cells enter a proliferative or apoptotic pathway. Our results show that nuclear CDK2 is associated with proliferation and that active cytoplasmic CDK2 is associated with apoptosis. This ®nding supports the notion that cyclin A-CDK2 is involved in both growth and death pathways, and that the fate of the cell is determined in part by the subcellular localization of active cyclin A-CDK2.
Results
Cells with increased CDK2 activity are more vulnerable to UV induced apoptosis and reducing CDK2 activity decreases apoptosis Previous studies have shown that apoptosis is increased in proliferating cell populations in certain forms of apoptosis (Danno and Horio, 1982; Nishioka and Welsh, 1994; Syljuasen and McBride, 1999) (Baker et al., 1994; Ophascharoensuk et al., 1998) . However, the mechanisms linking these processes are not fully elucidated. To test the hypothesis that the susceptibility of proliferating cells to apoptosis was due to increased CDK2 activity, apoptosis was induced by ultraviolet (UV) B irradiation in quiescent mouse mesangial cells (serum starved for 48 h) when CDK2 was inactive, and in proliferating mesangial cells (serum starved for 48 h, then add medium containing 20% FCS for 24 h) when CDK2 is active. Following UV exposure, apoptosis was increased in the proliferating cell population compared to UV exposure in a quiescent cell population (51.1+1.3% vs 27.7+2.1%, P50.01, 12 h after UV irradiation). These results demonstrate that when CDK2 is active in proliferating cells (data not shown), cells are more vulnerable to UV induced apoptosis.
To determine if apoptosis was associated with increased CDK2 activity, proliferating mesangial cells were serum starved, and then exposed to UV irradiation. In the absence of UV, apoptosis was detected 1.3+0.7%, 2.0+1.3%, 2.3+0.5% at 6, 9, 12 h, respectively. Following UV irradiation, apoptosis was detected 4.7+1.2%, 28.5+3.7%, 53.9+4.9% at 6, 9, 12 h respectively. We harvested total cell extracts at each time point and determined the CDK2 activity by histone H1 kinase assay. As expected, CDK2 activity decreased in control serum starved cells not exposed to UV (Figure 1a ). In contrast, there was a marked increase in CDK2 activity in serum starved cells exposed to UV irradiation ( Figure 1a) .
To con®rm that increased CDK2 activity participated in UV induced apoptosis, we inhibited CDK2 activity with Roscovitine and by transiently transfecting cells with a dominant negative CDK2 mutant. We and others have previously shown that the purine analogue Roscovitine reduces CDK2 activity Pippin et al., 1997) . Reducing CDK2 activity with Roscovitine signi®cantly decreased apoptosis at each time point following UV irradiation (Figure 1b) . We next determined the eect of dominant negative CDK2 mutant on apoptosis. As shown in Figure 1c , transfection of a dominant negative mutant CDK2 plasmid (CDK2-dn) signi®cantly inhibited UV-induced apoptosis compared to control cells transfected with wild type CDK2 plasmid (CDK2-wt) (27.1+3.1% vs 42.4+5.9%, CDK2-dn vs CDK2-wt, 12 h after UVirradiation, P50.01). These data demonstrated that active CDK2 participates in mesangial cell apoptosis induced by UV irradiation, and that UV-induced apoptosis is in part CDK2-dependent.
To ensure that the increase in CDK2 activity following UV irradiation was not due to increased DNA synthesis, BrdU incorporation was measured. In control cells not injured by UV, strong BrdU incorporation was detected in 49.6%+5.7 cells. In contrast, intensity of BrdU incorporation was markedly reduced in UV-treated cells as shown in Figure 2 . Taken together, these data demonstrated that following UV induced injury, CDK2 activity was increased in association with apoptosis and not DNA synthesis, and that reducing activity signi®cantly decreased apoptosis.
Cyclin A-CDK2 but not cyclin E-CDK2 nor cyclin B1-cdc2 activity is increased during apoptosis CDK2 is activated by cyclin E and cyclin A during G1 and S phases respectively. To examine which cyclin-CDK complex is activated during apoptosis, total cell lysates were immunoprecipitated with antibodies to CDK2, cdc2, cyclin A, cyclin E and cyclin B1, and their activities measured by histone-H1 kinase assay ( Figure 3a) . To determine the total protein levels, Western blot analysis was performed for each protein ( Figure 3b ). As expected, CDK2 and cdc2 activity were increased in proliferating cells, and were barely detected in control cells that were serum starved and not exposed to UV irradiation. In contrast to the increase in CDK2 activity following UV irradiation, cdc2 activity was not increased. Our results also showed that the increase in CDK2 activity was due to cyclin A, and not cyclin E. These results demonstrate that cyclin A-CDK2 was selectively active in apoptotic cells.
CDK2 localizes to the cytoplasm during apoptosis
In contrast to DNA synthesis which occurs in the nucleus, apoptosis typically begins in the cytoplasm. During quiescence, CDK2 is inactive and the protein is abundant in the cytoplasm. However, in order for DNA synthesis to occur, CDK2 protein moves, by yet poorly de®ned mechanisms, to the nucleus where it is activated by cyclins (Baptist et al., 1996; Bresnahan et were immunoprecipitated with antibodies to CDK2, cdc2, cyclin A, E and B1, followed by a histone-H1 kinase assay. There was a decrease in cyclin A-CDK2, cyclin E-CDK2 and cyclin B1-cdc2 activity in control cells not exposed to UV (lane 2). The activity of cyclin B1-cdc2 and cyclin E-CDK2 was also decreased in apoptotic UV treated cells (lane 3). In contrast, cyclin A-CDK2 activity remained increased in cells exposed to UV (lane 3). (b) Western blot. Total protein levels of CDK2 and CDC2 remained unchanged. The protein levels of cyclin A, cyclin E and cyclin B1 were decreased in control cells not exposed to UV (lane 2). The protein levels of cyclin E and cyclin B1 were also decreased in apoptotic UV treated cells (lane 3). In contrast, the protein level of cyclin A protein remained increased in cells exposed to UV (lane 3) al., 1996; Moore et al., 1999; Pagano et al., 1993) . To test the hypothesis that the subcellular localization of CDK2 determines if cells undergo either proliferation or apoptosis, we examined CDK2 protein localization. As shown in Figure 4a , less than 5% of quiescent cells stain positive for CDK2 in the nucleus. Moreover, the majority of quiescent cells displayed weak cytoplasmic staining for CDK2. In contrast, 70 ± 80% of proliferating cells stained positive for CDK2 in the nucleus (Figure 4b) .
A major ®nding in this study was that nuclear staining for CDK2 was reduced signi®cantly following the induction of apoptosis by UV irradiation in proliferating cells (Figure 4c ). Moreover, this coincided with an increase in cytoplasmic staining for CDK2. The change in the nuclear-cytoplasmic pattern of Figure 4 Cyclin A and CDK2 translocates to the cytoplasm during apoptosis. CDK2 (a) In mesangial cells rendered quiescent by serum deprived for 48 h, CDK2 immunostaining is positive in the cytoplasm. (b) In the absence of UV irradiation, CDK2 immunostaining is nuclear in proliferating and viable cells grown in medium containing 20% FCS. (c) When proliferating cells were exposed to UV irradiation, there was a marked decrease in nuclear staining for CDK2, and an increase in cytoplasmic staining 6 h after UV irradiation. (d) The cytoplasmic (C) and nuclear (N) localization of CDK2 was con®rmed by Western blot analysis performed on these protein fractions. Cyclin A. (e) Cyclin A immunostaining was not detected in quiescent mesangial cells, and was nuclear in proliferating cells grown in serum (f). (g) Inducing apoptosis in proliferating cells by UV irradiation was associated with a decrease in nuclear intensity for cyclin A and an increase in cytoplasmic staining 6 h after UV irradiation. (h) The cytoplasmic (C) and nuclear (N) localization of cyclin A was con®rmed by Western blot analysis CDK2 staining occurred within 6 h, and preceded the classical nuclear condensation of apoptosis. To con®rm the cytoplasmic subcellular localization of CDK2 following an apoptotic injury, Western blot analysis was also performed for CDK2 on separate nuclear and cytoplasmic protein fractions in control and UV irradiated cells. As expected, Western blot analysis showed that CDK2 protein was predominantly nuclear in proliferating cells not exposed to UV (Figure 4d ). In contrast, CDK2 protein was predominantly cytoplasmic in proliferating cells exposed to the apoptotic trigger, UV irradiation. The nuclear-cytoplasmic shift in CDK2 protein was not associated with any obvious dierences in total CDK2 protein abundance, because CDK2 levels remained unchanged in protein obtained from total cell lysates isolated in both proliferating and apoptotic cells (Figure 1a ).
Cytoplasmic CDK2 is activated by cyclin A
We showed earlier that cyclin A-CDK2, but not cyclin E-CDK2 activity increased during apoptosis. Accordingly, we measured cyclin A protein expression following the induction of apoptosis in proliferating cells. Cyclin A staining was barely detected in quiescent cells (Figure 4e ), but as expected, increased in the nucleus following serum stimulation (Figure 4f ). Six hours after the induction of apoptosis by UV irradiation, the intensity of nuclear cyclin A staining decreased signi®cantly in proliferating cells, and this coincided with an increase in cyclin A staining in the cytoplasm (Figure 4g) . Finally, the subcellular localization of cyclin A was con®rmed by Western blot ( Figure  4h ). Taken together, these data demonstrate that both cyclin A and CDK2 proteins translocate from the nucleus to the cytoplasm following the induction of apoptosis by UV irradiation in a proliferating cell population.
Monomeric CDK2 protein is inactive and requires the activation by a partner cyclin to function as a serinethreonine kinase. To ensure that cytoplasmic CDK2 was active following an apoptotic trigger, a histone H1-kinase assay was performed on separate nuclear and cytoplasmic protein fractions in control (no exposure to UV) and apoptotic (UV treated) cells. Similar to the protein, there was an increase in cyclin A-CDK2 activity in the cytoplasm of cells undergoing apoptosis ( Figure 5) . Thus, these results show that cyclin A and CDK2 protein were present in the cytoplasm following UV, and the complex remains active.
CDK2 translocation is not due to nuclear membrane breakdown
We were concerned that the translocation of CDK2 and cyclin A to the cytoplasm may have been simply due to disruption of the nuclear membrane. Two methods were used to show that the movement of cyclin A-CDK2 was indeed speci®c. First, immunostaining and Western blot analysis for the nuclear protein cyclin E, remained con®ned to the nucleus during apoptosis at a time when CDK2 was cytoplasmic (Figure 6 ). Similar results were obtained when we stained and blotted for heterogeneous nuclear ribonucleoprotein (hnRNP) K-protein (Bomsztyk et al., 1997) . Second, inhibiting apoptosis with the caspase inhibitor Z-VAD-FMK signi®cantly reduced UV induced apoptosis compare to control cells (53.9+4.9% vs 8.4+1.3%, P50.01), but did not interfere with the translocation of CDK2 (data not Figure 5 Cytoplasmic cyclin A-CDK2 activity is increased during apoptosis. CDK2 activity was measured by histone H1 kinase assay in cytoplasmic (C) and nuclear (N) protein fractions following serum withdrawal in cells 6 h after exposure to UV (+) or control cells not exposed to UV (7). Cyclin A-CDK2 activity was detected predominantly in the nuclear fraction in control cells not exposed to UV irradiation. In contrast, cytoplasmic cyclin A-CDK2 activity was more abundant in UV treated cells compared to the nuclear fraction Figure 6 Cyclin E remains in the nucleus during apoptosis. (a) In contrast to cyclin A and CDK2, immunostaining showed that cyclin E localized to the nucleus 6 h after UV-irradiation, and was not detected in the cytoplasm. (b) The nuclear (N) localization of cyclin E was con®rmed by Western blot analysis. B-tubulin was used as a cytoplasmic marker CDK2 and apoptosis K Hiromura et al shown). Taken together, these results showed that UV irradiation caused a speci®c movement of cyclin A-CDK2 from the nucleus to the cytoplasm in proliferating cells, and that this was not due to a generalized leakage of nuclear proteins. To determine if cytoplasmic cyclin A-CDK2 required new protein synthesis, cells were exposed to the protein synthesis inhibitor cycloheximide following UV irradiation. Cycloheximide did not aect the increase in cyclin A and CDK2 (data not shown), indicating that cytoplasmic CDK2 and cyclin A were preformed proteins, and that cytoplasmic cyclin A and CDK2 were not due to new protein synthesis.
CDK2 translocation does not require p53
Recent studies have shown that following DNA damage, the nuclear-cytoplasmic movement of cdc2 is sequestered in the cytoplasm by a p53-dependent and 14-3-3d mediated mechanism (Chan et al., 1999) . To determine if the translocation of CDK2 was p53-dependent, we studied mesangial cells derived from p53 null mice. Although p53 null mesangial cells undergo UV induced apoptosis, the translocation of cyclin A and CDK2 following UV irradiation was also recognized in p537/7 mesangial cells, and was comparable to p53+/+ cells (data not shown). These results demonstrate that nuclear-cytoplasmic CDK2 translocation is p53-independent.
Cyclin A-CDK2 is upstream of caspase-3 in the apoptotic pathway
The caspase cascade is a critical eector in mediating many forms of apoptosis, and recent studies have shown that caspase-3 is one of the ®nal downstream events required for UV induced cell death (Woo et al., 1998) . A previous study has shown that caspase-3 is upstream of CDK2 (Hakem et al., 1999) , yet others have shown that caspase-3 is downstream of CDK2 (Harvey et al., 2000; Levkau et al., 1998) . To determine if active cytoplasmic CDK2 was proximal to the activation of caspase-3, caspase-3 activity was measured in UV irradiated cells in the presence and absence of the CDK2 inhibitor, Roscovitine. Caspase-3 activity was signi®cantly increased in UV irradiated cells compared to the non-irradiated control cells. In contrast, Roscovitine signi®cantly reduced caspase-3 activity (Figure 7a) . Moreover, the cleaved active caspase-3 protein induced by UV was con®rmed by Western blot analysis, and this cleavage product was reduced when CDK2 activity was decreased ( Figure  7b ). These data demonstrate that CDK2 is upstream of caspase-3 in the apoptotic pathway in mesangial cells.
Discussion
In this study we show that the subcellular localization of CDK2 provides a novel mechanism whereby speci®c cell cycle proteins regulate apoptosis. Our data shows that when active CDK2 is nuclear, cells proliferate. In contrast, we showed that when UV was applied to proliferating cells, there is a translocation of active CDK2 to the cytoplasm, which is associated with apoptosis. These data show that the subcellular localization of active CDK2 determines the cell's growth or death fate.
Cyclin A-CDK2 is required for DNA synthesis during the S phase of the cell cycle (Pines, 1994; Reed, 1997; Shankland and Wolf, 2000) and is also rate limiting for the entry into mitosis (Furuno et al., 1999) . Although apoptosis is typically increased in proliferating cell populations in in¯ammatory diseases, such as occurs in mesangial cells in renal disease (Baker et al., 1994; Ophascharoensuk et al., 1998) , the mechanisms underlying the link between proliferation and apoptosis following injury are poorly de®ned. There is a growing body of evidence showing that both proliferation and apoptosis are closely linked at the level of the cell cycle. A coordinated activation of speci®c CDKs by partner cyclins is necessary for proliferation. However, we and others have more recently shown that certain CDKs, including CDK2 are also activated during apoptosis, and that inhibiting the kinase activity reduces apoptosis (Adachi et al., 2001; Dobashi et al., 1998; Gil-Gomez et al., 1998; Hakem et al., 1999; Hiromura et al., 1999; Hoang et al., 1994; Levkau et al., 1998; Meikrantz et al., 1994; Meikrantz and Schlegel, 1996; Park et al., 1998; Shi et al., 1994; Yao et al., 1996) . In the current study we reasoned that because apoptosis Figure 7 Cyclin A-CDK2 is upstream of caspase-3 in the apoptotic pathway. (a) Exposing mesangial cells to the CDK2 inhibitor Roscovitine (+; light bars) signi®cantly decreased caspase-3 activity at each time point after exposure to UV irradiation compared to control cells without Roscovitine (7; dark bars). Caspase-3 activity was expressed as the per cent increase compared to a pre-treated cells. *P50.01 vs Roscovitine (7). (b) The cleaved caspase-3 (active form) with (+) or without (7) Roscovitine was con®rmed by Western blot analysis typically begins in the cytoplasm, and that proliferation is governed within the nucleus, that the subcellular localization of CDK2 may determine the fate of the cell.
Our results showed that CDK2 protein translocates from the nucleus to the cytoplasm following exposure to an apoptotic trigger in proliferating cells. Moreover, CDK2 remains active by binding to cyclin A, but not cyclin E. Reducing CDK2 activity with Roscovitine or a dominant negative CDK2 mutant signi®cantly decreased UV-induced apoptosis, but does not completely abrogate apoptosis. This result suggests that there are CDK2-dependent and CDK2-independent pathways that mediate apoptosis. The movement of CDK2 to the cytoplasm was not a generalized phenomenon, because other nuclear speci®c proteins, cyclin E and K-protein, did not translocate to the cytoplasm following the same injury. Our results also showed that the cytoplasmic translocation of CDK2 was not p53-dependent, as translocation of CDK2 during UV induced apoptosis also occurred in p53 null mesangial cells.
Studies have shown that nuclear-cytoplasmic tracking of certain cell cycle proteins requires a nuclear export signal (NES), while others are under the control of a nuclear localization signal (NLS). Leptomycin B inhibits the export of proteins containing a NES, including cyclin B1 (Toyoshima et al., 1998; Yang et al., 1998) . Leptomycin B (gift from Minoru Yoshida, Tokyo University, Tokyo, Japan) (Yoshida and Horinouchi, 1999) did not inhibit the translocation of CDK2 to the cytoplasm (data not shown). The physiological shuttling of CDK2 from the cytoplasm to the nucleus during proliferation is poorly de®ned, and the movement of CDK2 from the nucleus to the cytoplasm described in this study during apoptosis also requires further investigation.
We attempted to elucidate potential cytoplasmic substrates whereby CDK2, a serine-threonine kinase, induces apoptosis. In the current study, we demonstrated that CDK2 activity is proximal to caspase-3 activation. A previous study has shown that CDK2 is upstream of caspases (Hakem et al., 1999) . Others have shown that CDK2 is downstream of caspases (Harvey et al., 2000; Levkau et al., 1998) . Thus, the role of CDK2 may depend on the cell type and/or the nature of the apoptotic stimulus. In order to determine if CDK2 binds to and phosphorylates candidate members of the Bcl-2 family, we immunoprecipitated CDK2 with Bcl-2, BAD and BAX. We were unable to show that these proteins colocalized with CDK2, nor could we demonstrate that these proteins were phosphorylated (data not shown).
In summary, our study provides a novel role for cyclin A-CDK2 in mediating both growth and death pathways. We propose that active nuclear cyclin A-CDK2 is required for cell proliferation, whereas active cytoplasmic cyclin A-CDK2 causes apoptosis and is upstream of caspase-3. The targets of CDK2 and the mechanisms underlying its translocation remain to be elucidated.
Materials and methods

Cell culture
Mouse mesangial cells were isolated from normal mice and from p537/7 mice (obtained from Chris Kemp, Fred Hutchinson Cancer Research Center, Seattle, WA, USA) as previously described (Hiromura et al., 1999) . Cells were passaged in growth medium of DMEM (Irvine Scienti®c, Santa Ana, CA, USA), 20% (v/v) Ham's-F12 (Irvine Scienti®c, Santa Ana, CA), 20% (v/v) FCS (Summit Biotechnology, Ft Collins, CO, USA), 2 mM glutamine (Sigma, St. Louis, MO, USA), 10 mM HEPES (Sigma), 100 U/ml penicillin -100 mg/ml streptomycin (Irvine Scienti®c) and 16trace element (Bio¯uids, Rockville, MD, USA) at 378C in humidi®ed 5% CO 2 in air.
Inducing apoptosis
Mesangial cells were plated (density 273610 4 cells/cm 2 ) in growth media. To synchronize cells in G0/G1, growing cells were washed three times with HBSS (without calcium and magnesium salts; Irvine Scienti®c), and then incubated in serum-free media (growth media without FCS) for 48 h. Apoptosis was induced by UV-B irradiation exposed to a 302 nM UV transilluminator source (LM-20e; VWR Scienti®c, Seattle, WA, USA) for 10 min as described by Martin and Cotter (1991) . This dose of UV was determined by a dose that induces 50% apoptosis at 12 h, in proliferating mesangial cells. The same dose eect is observed in Rat-1 ®broblasts (supplied by DM Hockenbery, Fred Hutchinson Cancer Research Center, Seattle, WA, USA). In selected experiments, CDK2 activity was reduced by adding Roscovitine (50 mM, Calbiochem, La Jolla, CA, USA) to the medium, and caspases were inhibited with Z-VAD-FMK (100 mM, Enzyme Systems Products; Livermore, CA, USA). To inhibit protein synthesis, cycloheximide (100 mM, Sigma) was used.
Measuring apoptosis
Apoptosis was measured by Hoechst 33342 (Molecular probes, Eugene, OR, USA) staining and by careful morphological analysis as previously reported (Hiromura et al., 1999; Mooney et al., 1997) . The percentage of apoptotic cells were measured in six randomly selected ®elds, and counted in triplicate in each experiment.
Immunohistochemical staining
To measure the expression of speci®c cell cycle proteins by immunostaining, cells were grown on 8-well permanox chamber slides (Nalge Nunc, Naperrville, IL, USA) and ®xed in methanol and acetone (1 : 1) at 7208C for 15 min. Cells were incubated overnight at 48C with primary antibodies to CDK2 (M2; rabbit polyclonal; Santa Cruz Biotechnology, Santa Cruz, CA, USA), cyclin A (C19; rabbit polyclonal; Santa Cruz Biotechnology), cyclin E (rabbit polyclonal; Upstate Biotechnology, Lake Placid, NY, USA), cyclin B1 (H433; rabbit polyclonal; Santa Cruz Biotechnology) and hnRNP K-protein (rabbit polyclonal; gift from Karol Bomsztyk, University of Washington, Seattle, WA, USA) diluted in 1% bovine serum albumin ± phosphate buer saline (PBS). A secondary biotinylated anti-rabbit IgG (Vector, Burlingame, CA, USA) was incubated at room temperature for 60 min, and immuno¯uorescent staining was detected by streptavidin-¯uorescein (Amersham Pharmacia Biotech, Piscataway, NJ, USA). Nuclei were counterstained with Hoechst 33342.
Histone H1 kinase assay and Western blot analysis
Total protein was extracted from mesangial cells (Primaria Tissue Culture Dish 100620 mm; Becton Dickinson Labware, Franklin Lakes, NJ, USA), using a buer containing 1% Triton, 10% glycerol, 20 mM HEPES, 100 mM NaCl (Sigma) and proteinase inhibitors (Boehringer Mannheim, Indianapolis, IN, USA) as previously reported (Hiromura et al., 1999) . To determine the subcellular localization and activity of speci®c cell cycle proteins, nuclear and cytoplasmic protein fractions were isolated using a modi®ed method by Orend et al. (1998) . In brief, cells were harvested by trypsin digestion, rinsed with cold PBS and placed on ice for 15 min in hypotonic buer A (10 mM HEPES pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT, 0.5 mM PMSF) and proteinase inhibitors. Nonidet P-40 (NP-40; ®nal concentration 0.1%; Sigma) was added, and suspensions were vortexed for 10 s. The cytoplasmic fraction was separated from the nuclear fraction by centrifugation for 5 min at 1400 g. The nuclear protein was extracted with buer C (20 mM HEPES pH 7.9, 0.4 mM, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1 mM PMSF). After 15 min rocking at 4 degrees, the supernatant was collected by centrifugation for 10 min at 17 000 g. Protein concentration was determined by the BCA protein assay (Pierce, Rockford, IL, USA) according to the manufacturer's directions.
The activities of CDK2 and cdc2 were measured by the histone H1 kinase assay as previously described (Hiromura et al., 1999) . Brie¯y, protein extracts (50 mg) were precipitated with antibodies to CDK2 (M2; Santa Cruz), cyclin A (C-19; Santa Cruz), cyclin E (Upstate Biotechnology), cyclin B1 (H433; Santa Cruz) and cdc2 (H297; rabbit polyclonal; Santa Cruz Biotechnology) using protein A sepharose (Amersham Pharmacia Biotech). The immunoprecipitation was incubated with histone H1 (Boehringer Mannheim) and 32 P-ATP (NEN Life Science Products, Boston, MA, USA), and resolved on a 15% SDS-polyacrylamide gel under reduced condition. The gel was exposed to autoradiographic ®lm (Amersham Pharmacia Biotech).
For Western blot analysis, 10 mg of protein extract (40 mg for caspase-3) was separated under reduced conditions on a 15% or 8% SDS-polyacrylamide gel and transferred to PVDF membrane (Immobilon-P; Millipore, Bedford, MA, USA). The membranes were incubated with primary antibodies to CDK2, cyclin A, cyclin E, K-protein, b-tubulin (mouse monoclonal; Sigma) and caspase-3 (H277; rabbit polyclonal; Santa Cruz Biotechnology) overnight at 48C, followed by incubation with an alkaline phosphataseconjugated secondary antibody (Promega, Madison, WI, USA) at room temperature for 60 min. Detection was determined with the chromagen 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium (Sigma).
BrdU incorporation
DNA synthesis was measured by BrdU incorporation as reported elsewhere (Hiromura et al., 1999) . Brie¯y, cells were incubated with BrdU (Amersham Pharmacia Biotech) for 3 h and incorporated BrdU was detected by anti-BrdU antibody (Amersham Pharmacia Biotech) followed by biotinylated anti-mouse IgG (Vector) and streptavidin-¯uorescein.
Transfection and analysis of apoptosis on transfected cells
To determine the role of CDK2 activity in apoptosis induced by UV irradiation, proliferating mesangial cells grown in 24-well plates were co-transfected with 0.8 mg of a dominantnegative mutant CDK2 plasmid (pCMV-CDK2-dn) and 0.2 mg pEGFP-N1 plasmids (Clontech Laboratories, Palo Alto, CA, USA) or 0.8 mg wild-type CDK2 plasmid (pCMV-CDK2-wt) and 0.2 mg pEGFP-N1, using GenePORTER TM Transfection Reagent (Gene therapy systems. San Diego, CA, USA), according to the manufacturer's instruction. Twentyfour hours after transfection, cells were exposed to UV-B irradiation. Twelve hours after UV-irradiation, doubleimmunostaining was performed with Hoechst 33342 to determine the percentage of transfected (green) cells undergoing apoptosis (nuclear condensation), and apoptosis was measured in 200 consecutive cells/well in triplicate.
Caspase-3 assay
To measure caspase-3 activity, 100 mg whole cell lysates were incubated with 100 mM Ac-DEVD-pNA (Calbiochem) in 200 ml of a buer (100 mM HEPES pH 7.4, 20% vol/vol glycerol, 5 mM DTT) in a 96-well plate. The plate was incubated at 378C and the release of free pNA, which absorbs at 405 nm, was monitored using plate reader, SpectraCount (Packard, Meriden, CT, USA). Caspase-3 activity in experimental cells was expressed as the fold increase compared to control cells.
Statistical analysis
Statistical analysis was performed using StatView 5.0.1 software program (Abacus Concepts, Berkeley, CA, USA); statistical signi®cance was evaluated using the Student's ttest.
